Benelux unquote
GP Profile: Apheon builds on family roots, mulls exits and reinvestment opportunities
Belgian GP, formerly known as Ergon, to continue to target family- and entrepreneur-owned European businesses
Eurazeo taps Rothschild for DORC exit
Upcoming process for Dutch medical equipment group expected to launch in September
Active Capital in EUR 150m fundraise; SIF strategy and portfolio companies eye buys
Industrials-focused sponsor expects reshoring trend to generate uptick in opportunities
Bencis prepares Kooi for sale via Lincoln
Netherlands-based video surveillance business was founded in 2010 and acquired by Bencis in 2018
Dutch VC NLC Health aims to raise a further EUR 80m for fourth fund
Plans to back companies created by NLC Venture Builder across medtech, biotech and digital tech
BioGeneration Ventures closes Fund V on EUR 150m
LP appetite for healthcare has remained strong in spite of a tough fundraising market
Dutch sponsor Egeria gears up for new fund launch next year
GP’s 2017-vintage, EUR 800m current fund is expected to be fully deployed within 12-18 months
Strada Partners heads for 2024 final close for EUR 150m debut fund
Emerging Belgian manager was formed last year and will ink deals with EUR 5m-EUR 50m equity tickets
Capvis-backed Gotha Cosmetics to grant PAI Partners exclusivity ‘in coming days’
Capvis took a majority stake in the Netherlands-based colour cosmetics firm in 2016
Eurazeo-backed DORC catches the eye of dealmakers with H2 process anticipated
Eurazeo acquired the Dutch ophthalmic surgical equipment producer for EUR 430m in 2019
Bugaboo backer Bain strolls back to market for H2 2022 launch
Sale of pram maker was initially launched last year but did not proceed due to credit market and consumer sector concerns
Egeria to exit GoodLife Foods in SBO to IK Partners
Acquisition of Dutch frozen snack maker marks 13th investment from IK IX Fund
Polestar Capital to raise up to EUR 500m for new e-mobility investment strategy
Dutch GP plans to close new vehicle in mid-2024 as Circular Debt fundraising continues
Heran Partners nears full deployment of debut fund, mulls next fundraise
Health tech-focused VC is seeking three further software and hardware deals from EUR 75m debut vehicle
Carbon Equity open to commitments for new impact fund with EUR 125m hard-cap
Netherlands-based fund-of-funds manager will broaden its strategy to incorporate co-investments for its second fund
Gimv acquires majority stake in Witec
Belgium-based Gimv set to support Netherlands-headquartered contract design manufacturer’s growth
4Impact heads for year-end close for EUR 125m second fund
Founded by ex-Goldman Sachs team, impact VC firm has made one investment from its latest fund so far
Forbion raises combined EUR 1.35bn for venture and growth funds
Ventures Fund VI closes on EUR 750m and Growth Opportunities II on EUR 600m with both upsized by over 60%
Gilde Healthcare hits EUR 600m target for Venture&Growth VI
Fund is 50% larger than predecessor thanks to “loyal” LP base; seeks late-stage deployment in medtech, digital health and therapeutics
Houlihan Lokey poaches Nielen Schuman’s Theys to open up Antwerp office
Hire to cement Houlihan Lokey’s position in Belgium, which represents 30% of the advisor’s Benelux deals
Mayfair kicks off third fund deployment with Jonckers buyout
Sponsor has seen a GBP 800m increase in AUM since its most recent exit in October 2022
Large-cap sponsors circle Qiagen bioinformatics arm ahead of indicative bids
Potential PE bidders are assessing performance and market share of the Netherlands-headquartered business
Bencis raises EUR 123m continuation fund for group of Fund IV assets
Secondary deal was led by Committed Advisors and will provide backing for future growth of four portfolio companies
Newton Biocapital heads for year-end close for second, EUR 150m life sciences fund
Belgian-Japanese VC has raised EUR 50m to date and is lining up exits from its debut fund